Directly go to
|About Drug Innovation|
The Master’s programme Drug Innovation focuses on diagnostics and the improvement and management of small molecule and biomolecular drugs. It covers many topics such as the development of new vaccines and the study of antibodies, gene therapeutics, and medical nutrition. Once developed, a new drug then needs to go through approval, which raises a whole new set of challenges, for example the establishment of new methods and criteria for evaluating the quality, efficacy, safety, and performance of the drug.
Go to the page 'Study programme' for more information